340 related articles for article (PubMed ID: 4132421)
1. Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients.
Mortimer CH; Tunbridge WM; Carr D; Yeomans L; Lind T; Coy DH; Bloom SR; Kastin A; Mallinson CN; Besser GM; Schally AV; Hall R
Lancet; 1974 Apr; 1(7860):697-701. PubMed ID: 4132421
[No Abstract] [Full Text] [Related]
2. Effects of metformin on plasma glucose, insulin, FFA, glucagon, growth hormone and cortisol responses to oral glucose in subjects with chemical diabetes.
Giugliano D; Torella R; Improta L; Scognamiglio G
Farmaco Prat; 1979 Jan; 34(1):32-41. PubMed ID: 378687
[No Abstract] [Full Text] [Related]
3. Effect of somatostatin in patients with acromegaly: suppression of growth hormone, prolactin, insulin and glucose levels.
Yen SS; Siler TM; DeVane GW
N Engl J Med; 1974 Apr; 290(17):935-8. PubMed ID: 4593614
[No Abstract] [Full Text] [Related]
4. Excessive glucagon responses to arginine in active acromegaly.
Goldfine ID; Kirsteins L; Lawrence AM
Horm Metab Res; 1972 Mar; 4(2):97-100. PubMed ID: 5063721
[No Abstract] [Full Text] [Related]
5. Abnormal serum growth hormone responses in genetically potential-diabetic male patients with normal oral glucose tolerance: evidence for an insulin-like action of growth hormone in vivo.
Sönksen PH; Soeldner JS; Gleason RE; Boden G
Diabetologia; 1973 Oct; 9(5):426-37. PubMed ID: 4773203
[No Abstract] [Full Text] [Related]
6. Long-term infusion of growth hormone release inhibiting hormone in acromegaly: effects on pituitary and pancreatic hormones.
Besser GM; Mortimer CH; McNeilly AS; Thorner MO; Batistoni GA; Bloom SR; Kastrup KW; Hanssen KF; Hall R; Coy DH; Kastin AJ; Schally AV
Br Med J; 1974 Dec; 4(5945):622-7. PubMed ID: 4374289
[TBL] [Abstract][Full Text] [Related]
7. Plasma glucagon and insulin concentrations in acromegaly.
Trimble ER; Atkinson AB; Buchanan KD; Hadden DR
J Clin Endocrinol Metab; 1980 Sep; 51(3):626-31. PubMed ID: 6997331
[TBL] [Abstract][Full Text] [Related]
8. The regulation of plasma ketone body concentration by counter-regulatory hormones in man. II. Effects of growth hormone in diabetic man.
Schade DS; Eaton RP; Peake GT
Diabetes; 1978 Sep; 27(9):916-24. PubMed ID: 689302
[No Abstract] [Full Text] [Related]
9. Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications.
Gerich JE; Lorenzi M; Schneider V; Karam JH; Rivier J; Guillemin R; Forsham PH
N Engl J Med; 1974 Sep; 291(11):544-7. PubMed ID: 4604408
[No Abstract] [Full Text] [Related]
10. [Growth hormone: interpretation of the test results].
Kato Y; Imura H
Nihon Rinsho; 1969 Mar; ():Suppl:958-68. PubMed ID: 4948305
[No Abstract] [Full Text] [Related]
11. Dissociated effects of somatostatin analogs on arginine-induced insulin, glucagon and growth hormone release in acromegalic patients.
Wajchenberg BL; Cesar FP; Leme CE; Borghi VC; Souza VC; Souza IT; Neto DG; Germek OA; Coy DH; Comaru-Schally AM
Horm Metab Res; 1983 Oct; 15(10):471-4. PubMed ID: 6139329
[TBL] [Abstract][Full Text] [Related]
12. Effect of somatostatin on blood glucose, plasma growth hormone, insulin, and free fatty acids in normal subjects and acromegalic patients.
Peracchi M; Reschini E; Cantalamessa L; Giustina G; Cavagnini F; Pinto M; Bulgheroni P
Metabolism; 1974 Nov; 23(11):1009-15. PubMed ID: 4418535
[No Abstract] [Full Text] [Related]
13. Growth hormone release inhibiting hormone in acromegaly.
Besser GM; Mortimer CH; Carr D; Schally AV; Coy DH; Evered D; Kastin AJ; Tunbridge WM; Thorner MO; Hall R
Br Med J; 1974 Mar; 1(5904):352-5. PubMed ID: 4594581
[TBL] [Abstract][Full Text] [Related]
14. Serum glucagon after arginine infusion in aged and young subjects.
Ferrero E; Casale G; De Nicola P
J Am Geriatr Soc; 1980 Jun; 28(6):285-7. PubMed ID: 6989881
[TBL] [Abstract][Full Text] [Related]
15. Abnormalities of growth hormone release in response to human pancreatic growth hormone releasing factor (GRF (1-44) ) in acromegaly and hypopituitarism.
Wood SM; Ch'ng JL; Adams EF; Webster JD; Joplin GF; Mashiter K; Bloom SR
Br Med J (Clin Res Ed); 1983 May; 286(6379):1687-91. PubMed ID: 6405935
[TBL] [Abstract][Full Text] [Related]
16. [Courses of blood sugar, insulin, growth hormone, free fatty acids and glycerin following intravenous and oral glucose load in children of diabetic mothers and of a healthy control group].
Amendt P
Acta Paediatr Acad Sci Hung; 1975; 16(3-4):281-98. PubMed ID: 1224977
[No Abstract] [Full Text] [Related]
17. Growth hormone modulation of arginine-induced glucagon release: studies of isolated growth hormone deficiency and acromegaly.
Seino Y; Taminato T; Goto Y; Inoue Y; Kadowaki S; Hattori M; Mori K; Kato Y; Matsukura S; Imura H
Clin Endocrinol (Oxf); 1978 Dec; 9(6):563-70. PubMed ID: 747897
[TBL] [Abstract][Full Text] [Related]
18. [Assay of somatotropic hormone].
Annee Endocrinol; 1967; 19():77-87. PubMed ID: 4873366
[No Abstract] [Full Text] [Related]
19. The clinical application of the measurement of human growth hormone.
Jacobs HS
J Endocrinol; 1972 Sep; 54(3):xxvi-xxvii. PubMed ID: 5071386
[No Abstract] [Full Text] [Related]
20. [The arginine test in functional semeiology of the incretion of the somatotrophic hormone].
Giordano G; Marugo M; Minuto F; Barreca T
Folia Endocrinol; 1971; 24(3):247-67. PubMed ID: 5171726
[No Abstract] [Full Text] [Related]
[Next] [New Search]
